246710 — T&R Biofab Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapSucker Stock

Market Cap
KR₩105bn
Enterprise Value
KR₩137bn
Revenue
KR₩5bn

Annual balance sheet for T&R Biofab Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	ARS	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	36,879	58,166	40,423	51,747	17,276
Net Total Accounts Receivable
Net Total Receivables	1,161	1,403	1,931	2,088	3,066
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	42,834	63,676	46,835	57,558	26,294
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	2,616	10,996	20,287	34,836	61,330
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	48,505	82,234	75,938	99,816	98,453
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	1,209	1,671	29,102	50,949	40,846
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	2,453	40,541	36,675	68,619	74,242
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
ESOP Debt Guarantee
Unrealized Gain / Loss
Other Equity
Total Equity	46,052	41,693	39,263	31,197	24,211
Total Liabilities & Shareholders' Equity	48,505	82,234	75,938	99,816	98,453
Total Common Shares Outstanding
Total Preferred Shares Outstanding